“cystic-fibrosis-foundation” Archives

Entry Author Date Location
After “Hubris” and Its HCV Collapse, Can Vertex Avoid Same Mistakes? 10/18/16 Boston
Inhaled-Drug Maker Savara Buys European Biotech With Two Candidates 06/21/16 Texas
Austin Biotech Savara Nets $20M in Series C for Phase 3 Study 03/01/16 Texas
Even With New Crowdfunding Rules, No Easy Path Forward For Biotechs 11/03/15 National
East Coast Biotech Roundup: Forum, Crossovers, Immuno-Oncology & More 04/24/15 Boston
Crowdfunding is Banging on Biotech’s Door. Will We Let It In? 01/21/15 Boston
Rethinking Venture Philanthropy After the Kalydeco Windfall 12/22/14 Boston
East Coast Biotech Roundup: Agios, Vertex, Epizyme, Celldex, & More 11/21/14 Boston
CF Foundation Cashes Out on Kalydeco in $3.3B Sale to Royalty Pharma 11/19/14 Boston
BioPontis, Reborn as Nonprofit, Takes On Rare Disease Drugs 10/20/14 Raleigh Durham
Austin Biotech Savara Nets $10M to Develop Cystic Fibrosis Drug 10/06/14 Texas
Austin Startup Savara Wins Research Award for CF Therapy 10/17/13 Texas
Savara Enters the Proving Ground With Inhalable Antibiotic for CF 05/01/13 Texas
East Coast Life Sciences Roundup: Insider Trading, Shire, Pfizer 11/23/12 Boston
Pfizer, Cystic Fibrosis Foundation in $58 Million Pact 11/19/12 New York
The New Power Players in Drug R&D Are Wearing Bright T-Shirts 10/29/12 National
Vertex Wins EU Approval for Cystic Fibrosis Drug 07/27/12 Boston
Investing in Biotech Isn’t Just for Investors Anymore 04/09/12 National
Vertex’s Big Day Felt Like Moon Landing, Seattle Researcher Says 02/01/12 Boston
Vertex Gets FDA Go-Ahead To Sell New Cystic Fibrosis Drug 01/31/12 Boston
Vertex Seeks FDA Green Light for Cystic Fibrosis Drug, Second Potential Hit of Big Year 10/19/11 Boston
aTyr Pharma Looks to Strike Balance Between Nonprofits, and Really Big For-Profits 07/06/11 San Diego
Vertex CF Drug Shines in Late-Stage Study in Children 03/29/11 Boston
Vertex Nails Pivotal Study for Cystic Fibrosis, Racing Toward Market With Second Drug 02/23/11 Boston
Philanthropist John Flatley Starts Venture Group to Back New Cystic Fibrosis Treatments 01/27/11 Boston
Patients’ Parents Upset By FDA Panel’s Rejection of Lilly/Alnara’s Cystic Fibrosis Drug 01/19/11 Boston
Eli Lilly Pays up to $380M for Alnara Pharma 07/20/10 Boston
Alnara Pharma Used “Flexible” Strategy on Road to Eli Lilly Deal 07/08/10 Boston
Drug Giant Eli Lilly Buys Alnara Pharma To Get Cystic Fibrosis Drug 07/02/10 Boston
Prominent Flatley Family Launches Boston Nonprofit for Cystic Fibrosis Drug Research 03/03/10 Boston
Page 1 of 2 next page »